Joint venture China, subsidiary (WFOE) or hybrid?
By Frank-Christan Raffel Frank-Christian Raffel has been analyzing and shaping the strategy and corporate form of European companies in China and Southeast Asia since 1997, when he conducted a broad-based study in cooperation with the Hong Kong and Shanghai Chambers of Commerce. It is remarkable how often we hear the question even today, in the […]
MRL Advisors takes a stake in EMTS Group Pte. Ltd. in Singapore and Manila
By Frank-Christian Raffel EMTS – European Medtech Services – has set itself the goal of improving the availability of medical technology in Southeast Asia. MRL Advisors has joined as a founding partner. The former top manager of the Austrian Fresenius-VAMED, Matthias Köhler, had the idea to found the company when Southeast Asia was no longer […]
Dr. Franz Köhler Chemie: Establishment of its own subsidiary in China with an innovative shareholder model
By Frank-Christian Raffel Dr. Franz Köhler Chemie (DFKC) is a research-intensive and innovative pharmaceutical company and is owner-managed in the third generation. DFKC is, among other things, the manufacturer of the organ-protective solution CUSTODIOL©, which is distributed worldwide by DFKC. Starting Point China is one of the most important markets in the world for DFKC. […]